A concise overview of Europe’s AI-driven drug discovery market: market trajectory, key technologies, leading countries, main challenges, and strategic opportunities.
Europe’s AI Drug Discovery Surge: Trends, Players, and What’s Next Read More »
How Amazon’s Health AI agent uses agentic AI, One Medical and Amazon Pharmacy ties, HIPAA safeguards, and human oversight to personalize patient care.
Amazon Health AI Agent: Personalizing Patient Support and Care Coordination Read More »
BioSee AI from the University of Nottingham uses ultrasonic and optical sensing with machine learning to deliver affordable, non-invasive real-time bioprocess monitoring for biomanufacturers.
BioSee AI: Real-Time, Low-Cost Monitoring That Brings Smarter Bioprocessing to SMEs Read More »
UK physicians and the RCP call for a national regulatory framework for AI in healthcare. Read the practical recommendations on liability, data governance, interoperability, and the MHRA’s role in balancing patient safety with innovation.
PanMETAI combines AI and NMR metabolomics via liquid biopsy to detect pancreatic cancer earlier. Cross-ethnic validation in Taiwan and Lithuania shows strong diagnostic promise.
PanMETAI: AI + NMR Metabolomics Bring Early Pancreatic Cancer Detection Within Reach Read More »
BrainADNet uses resting-state brain signals and graph convolutional networks to improve Major Depressive Disorder diagnosis and reveal sex-specific neural patterns.
AI Breakthrough: Sharpening Depression Diagnosis with Brain Networks Read More »
A new AI approach links genomics, imaging, and clinical data to tailor cancer therapies, speed drug discovery, and improve trial matching. What this means now and next.
AI Accelerates Personalized Cancer Treatment Breakthroughs Read More »
Public backs the NHS App but is wary of AI ‘doctor in your pocket’. Learn how data governance, cyber security and targeted investment can build trust.
Public Trust and AI in UK Healthcare: How to Win Acceptance Read More »
How pharma can convert fragmented legacy data into a living scientific memory to accelerate AI-driven drug discovery and secure lasting competitive advantage.
AI Drug Discovery’s Hidden Power: Transforming Legacy Data into Living Scientific Memory Read More »
A Health Foundation study shows uneven public and NHS staff views on AI in UK healthcare. Safety, human oversight and tailored engagement are needed to build trust and avoid widening inequalities.
Public & Staff Divide: Trust and the Future of AI in UK Healthcare Read More »
